Skip to content

Efficacy of a new Vitamin E foam in prevention of early skin damage in patients undergoing radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN28188789
Enrollment
80
Registered
2005-11-10
Start date
2004-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin damage after radiotherapy Cancer Breast

Interventions

Vitamin E foam topical application versus emollient standard cream

Sponsors

Mipharm (Italy)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients undergoing radiotherapy for breast or thoracic cancer

Exclusion criteria

Exclusion criteria: Known sensibility to topical Vitamin E

Design outcomes

Primary

MeasureTime frame
1. Radiation Therapy Oncology Group (RTOG) skin score 2. Skin damage score

Secondary

MeasureTime frame
Tolerability

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026